leisure time -WSS

leisure time

author：focus 2025-09-27 10:05:34 - browse：18

Person wearing a blue glove holding money against a blue backdrop. — Adobe

Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of dollars for several drugmakers. But investment in experimental vaccines for dozens of other diseases remains modest and should be much higher, according to a new biotechnology industry report.

Even with the historic effort to develop coronavirus vaccines, including shots created by Cambridge, Mass.-based Moderna, drugmakers developing new vaccines for infectious diseases received 3.4% of all venture capital raised for biopharma companies in the past 10 years, for a total of $6.5 billion, the report said.

In comparison, firms with potential cancer drugs received 38% of venture capital, or $72.6 billion — 12 times as much — during the same period, according to the report by the Biotechnology Innovation Organization, or BIO, the world’s largest biotech trade group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： CDC Director Mandy Cohen on transparency, trust, and health

knowledge

WSS

STAT Summit: Michael J. Fox on progress in Parkinson's research

Biogen says it will cut costs by $700 million, slash 1,000 jobs

First Opinion Podcast: Long Covid needs a new approach

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Solve the antibiotic resistance crisis with preventive drugs

Senate committee scrutinizes Medicare Advantage brokers

Wikipedia

leisure time

focus

BioMarin wins approval for gene therapy to treat hemophilia A

The haunting brain science of long Covid

Wildfire smoke exposes gaps in outdoor worker protections

New Alzheimer's drugs heat up race for early detection blood tests

Drug repurposing or repositioning? The language matters

Hospital price transparency does save money, advocate argues

Novavax promises a turnaround & Lilly roils the obesity market

In the gardens at Boston Children's Hospital, families find sanctuary

Medicare proposal to cover medical devices draws a mixed reaction

Beam Therapeutics to lay off 20% of its staff, re

hotspot

What it's like to live with paralysis for one psychologist

Rise in cancer among younger people worries and puzzles doctors

Search called off for baby washed away in Pennsylvania flash flood

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Impact of Dobbs ruling felt at reproductive medicine meeting

Impact of Dobbs ruling felt at reproductive medicine meeting

knowledge

knowledge

focus

entertainment